ORIGINAL ARTICLE
Studying significance of apoptosis in mediating tolbutamide-induced teratogenesis in vitro
Gyanendra Singh,
Akhilesh Kumar,
Neeraj Sinha,
Corresponding Author
Gyanendra Singh
Present address: Gene Therapy & Louisiana Vaccine Center, School of Medicine, LSU Health Sciences Center, New Orleans 70112, LA, USA.
Correspondence and reprints: [email protected]; [email protected]Search for more papers by this authorAkhilesh Kumar
Division of Toxicology, Central Drug Research Institute, Lucknow 226001, India
Search for more papers by this authorCorresponding Author
Neeraj Sinha
Correspondence and reprints: [email protected]; [email protected]Search for more papers by this authorGyanendra Singh,
Akhilesh Kumar,
Neeraj Sinha,
Corresponding Author
Gyanendra Singh
Present address: Gene Therapy & Louisiana Vaccine Center, School of Medicine, LSU Health Sciences Center, New Orleans 70112, LA, USA.
Correspondence and reprints: [email protected]; [email protected]Search for more papers by this authorAkhilesh Kumar
Division of Toxicology, Central Drug Research Institute, Lucknow 226001, India
Search for more papers by this authorCorresponding Author
Neeraj Sinha
Correspondence and reprints: [email protected]; [email protected]Search for more papers by this authorCDRI communication number 8046.
Abstract
The incidence of type 2 diabetes mellitus (non-insulin-dependent diabetes mellitus) is growing worldwide and poses a serious public health problem in a current paradigm of changing life style and food habits. Tolbutamide (sulfonylurea) is among the commonly used anti-diabetic drugs worldwide for treating type 2 diabetes and is known to cause congenital malformations in animals. In this study, the effect of tolbutamide on major organogenesis period and the possible involvement of apoptosis in mediating congenital malformations have been carried out. In the present study design, post-implantation rat embryos of day 11 were cultured for 24 h with various concentrations of tolbutamide, i.e., 10, 100, and 1000 μg/mL cultures, respectively. The growth and developmental of each embryo was evaluated and compared with control ones for the presence of any malformations. The tolbutamide decreased all growth and developmental parameters in a concentration-dependent manner, when compared with control. However, exposure to tolbutamide at 10 μg/mL culture did not show any significant effect on embryonic growth and development in vitro. In parallel to this, flow cytometric analysis (cell cycle and annexin V binding) and DNA fragmentation assay were carried out followed by quantitation by 3′-OH labeling of cultured rat embryos to examine the role of apoptosis in bringing about tolbutamide-induced teratogenesis. All results were found to be dose dependent and an increase in apoptosis in embryonic tissues may be related to the increased risk of congenital malformations. The outcome of the research suggested that apoptosis might be involved in mediating teratogenesis of tolbutamide in vitro. Further research is warranted to fully understand this mechanism.
References
- 1 Arends M.J., Wyllie A.H. Apoptosis: mechanisms and roles in pathology. Int. Rev. Exp. Pathol. (1991) 32 223–254.
- 2 Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science (1995) 267 1456–1462.
- 3
Lee Q.P.,
Park H.W.,
Thayer J.,
Mirkes P.E.,
Juchau M.R.
Apoptosis induced in cultured rat embryos by intra-amniotically microinjected sodium nitroprusside.
Teratology (1996) 53
21–30.
10.1002/(SICI)1096-9926(199601)53:1<21::AID-TERA3>3.0.CO;2-C CAS PubMed Web of Science® Google Scholar
- 4 Dong J., Sulik K.K., Chen S.Y. The role of NOX enzymes in ethanol-induced oxidative stress and apoptosis in mouse embryos. Toxicol. Lett. (2010) 193 94–100.
- 5 Hansen J.M. Oxidative stress as a mechanism of teratogenesis. Birth Defects Res. C Embryo Today (2006) 78 293–307.
- 6 Pekar O., Molotski N., Savion S., Fein A., Toder V., Torchinsky A. p53 regulates cyclophosphamide teratogenesis by controlling caspases 3, 8, 9 activation and NF-kappaB DNA binding. Reproduction (2007) 134 379–388.
- 7 Sarkar S.A., Sharma R.P. Expression of c-Myc and other apoptosis-related genes in Swiss Webster mouse fetuses after maternal exposure to all trans-retinoic acid. Reprod. Toxicol. (2002) 16 245–252.
- 8 Kerr J.F. Shrinkage necrosis: a distinct mode of cellular death. J. Pathol. (1971) 105 13–20.
- 9 Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer (1972) 26 239–257.
- 10 Smoak I.W. Teratogenic effects of tolbutamide on early-somite mouse embryos in vitro. Diabetes Res. Clin. Pract. (1992) 17 161–167.
- 11 Belisle R.J., Long S.Y. Tolbutamide treatment of pregnant mice: repeated administration reduces fetal lethality. Teratology (1976) 13 65–70.
- 12 McColl J.D., Robinson S., Globus M. Effect of some therapeutic agents on the rabbit fetus. Toxicol. Appl. Pharmacol. (1967) 10 244–252.
- 13 Smithberg M., Runner M.N. Teratogenic effects of hypoglycemic treatments in inbred strains of mice. Am. J. Anat. (1963) 113 479–489.
- 14 Mills J.L., Baker L., Goldman A.S. Malformations in infants of diabetic mothers occur before the seventh gestational week. Implications for treatment. Diabetes (1979) 28 292–293.
- 15 Ito T., Ando H., Suzuki T. et al. Identification of a primary target of thalidomide teratogenicity. Science (2010) 327 1345–1350.
- 16
Miller M.T.,
Stromland K.
Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses.
Teratology (1999) 60
306–321.
10.1002/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y CAS PubMed Web of Science® Google Scholar
- 17 Stromland K., Pinazo-Duran M.D. Ophthalmic involvement in the fetal alcohol syndrome: clinical and animal model studies. Alcohol Alcohol. (2002) 37 2–8.
- 18 Therapontos C., Erskine L., Gardner E.R., Figg W.D., Vargesson N. Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation. Proc. Natl. Acad. Sci. USA (2009) 106 8573–8578.
- 19 Coopersmith H., Kerbel N.C. Drugs and congenital anomalies. Can. Med. Assoc. J. (1962) 87 193.
- 20 Larsson Y., Sterky G. Possible teratogenic effect of tolbutamide in pregnant prediabeti. Lancet (1960) 2 1424–1425.
- 21 Schiff D., Aranda J.V., Stern L. Neonatal thrombocytopenia and congenital malformations associated with administration of tolbutamide to the mother. J. Pediatr. (1970) 77 457–458.
- 22 Soler N.G., Walsh C.H., Malins J.M. Congenital malformations in infants of diabetic mothers. Q. J. Med. (1976) 45 303–313.
- 23 Lowy C., Beard R.W., Goldschmidt J. Congenital malformations in babies of diabetic mothers. Diabet. Med. (1986) 3 458–462.
- 24 Dolger H., Bookman J.J., Nechemias C. Tolbutamide in pregnancy and diabetes. J. Mt. Sinai Hosp. N. Y. (1969) 36 471–474.
- 25 Malins J.M., Cooke A.M., Pyke D.A., Fitzgerald M.G. Sulphonylurea drugs in pregnancy. Br. Med. J. (1964) 2 187.
- 26 Notelovitz M. Sulphonylurea therapy in the treatment of the pregnant diabetic. S. Afr. Med. J. (1971) 45 226–229.
- 27 Piacquadio K., Hollingsworth D.R., Murphy H. Effects of in-utero exposure to oral hypoglycaemic drugs. Lancet (1991) 338 866–869.
- 28 Ferner R.E., Neil H.A. Sulphonylureas and hypoglycaemia. Br. Med. J. (Clin. Res. Ed.). (1988) 296 949–950.
- 29 Akazawa M., Akazawa S., Hashimoto M. et al. Effects of brief exposure to insulin-induced hypoglycemic serum during organogenesis in rat embryo culture. Diabetes (1989) 38 1573–1578.
- 30 Buchanan T.A., Schemmer J.K., Freinkel N. Embryotoxic effects of brief maternal insulin-hypoglycemia during organogenesis in the rat. J. Clin. Invest. (1986) 78 643–649.
- 31 Smoak I.W., Sadler T.W. Embryopathic effects of short-term exposure to hypoglycemia in mouse embryos in vitro. Am. J. Obstet. Gynecol. (1990) 163 619–624.
- 32 Ellis-Hutchings R.G., Carney E.W. Whole embryo culture: a “New” technique that enabled decades of mechanistic discoveries. Birth Defects Res. B Dev. Reprod. Toxicol. (2010) 89 304–312.
- 33 Luijten M., van Beelen V.A., Verhoef A. et al. Transcriptomics analysis of retinoic acid embryotoxicity in rat postimplantation whole embryo culture. Reprod. Toxicol. (2010) 30 333–340.
- 34 Singh G., Sinha N. Involvement of apoptosis in mediating mitomycin C-induced teratogenesis in vitro. Toxicol. Mech. Methods (2010) 20 190–196.
- 35 Singh G., Sinha N., Koushik C.J., Mathur S.K., Srivastava S. Detecting role of apoptosis in mediating cyclophosphamide induced teratogenesis in vitro. Toxicol. Mech. Methods (2005) 15 391–397.
- 36 Singh G., Sinha N., Mahipag G.S. Role of apoptosis in mediating salicylic acid-induced teratogenesis in vitro. Toxicol. Mech. Methods (2009) 19 161–168.
- 37 Arends M.J., Morris R.G., Wyllie A.H. Apoptosis. The role of the endonuclease. Am. J. Pathol. (1990) 136 593–608.
- 38 Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (1980) 284 555–556.
- 39 New D.A. Whole-embryo culture and the study of mammalian embryos during organogenesis. Biol. Rev. Camb. Philos. Soc. (1978) 53 81–122.
- 40 Chernoff N., Rogers J.M., Alles A.J. et al. Cell cycle alterations and cell death in cyclophosphamide teratogenesis. Teratog. Carcinog. Mutagen. (1989) 9 199–209.
- 41 Tilly J.L., Hsueh A.J. Microscale autoradiographic method for the qualitative and quantitative analysis of apoptotic DNA fragmentation. J. Cell. Physiol. (1993) 154 519–526.
- 42
Darzynkiewicz Z.,
Juan G.,
Li X.,
Gorczyca W.,
Murakami T.,
Traganos F.
Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis).
Cytometry (1997) 27
1–20.
10.1002/(SICI)1097-0320(19970101)27:1<1::AID-CYTO2>3.0.CO;2-L CAS PubMed Web of Science® Google Scholar
- 43 Del Bino G., Darzynkiewicz Z., Degraef C., Mosselmans R., Fokan D., Galand P. Comparison of methods based on annexin-V binding, DNA content or TUNEL for evaluating cell death in HL-60 and adherent MCF-7 cells. Cell Prolif. (1999) 32 25–37.
- 44 Allen V.M., Armson B.A., Wilson R.D. et al. Teratogenicity associated with pre-existing and gestational diabetes. J. Obstet. Gynaecol. Can. (2007) 29 927–944.
- 45 Corrigan N., Brazil D.P., McAuliffe F. Fetal cardiac effects of maternal hyperglycemia during pregnancy. Birth Defects Res. A Clin. Mol. Teratol. (2009) 85 523–530.
- 46 Efanova I.B., Zaitsev S.V., Zhivotovsky B. et al. Glucose and tolbutamide induce apoptosis in pancreatic beta-cells. A process dependent on intracellular Ca2+ concentration. J. Biol. Chem. (1998) 273 33501–33507.
- 47 Marchetti P., Navalesi R. Pharmacokinetic–pharmacodynamic relationships of oral hypoglycaemic agents. An update. Clin. Pharmacokinet. (1989) 16 100–128.
- 48 Yu W., Niwa T., Miura Y. et al. Calmodulin overexpression causes Ca(2+)-dependent apoptosis of pancreatic beta cells, which can be prevented by inhibition of nitric oxide synthase. Lab. Invest. (2002) 82 1229–1239.
- 49 Sturgess N.C., Ashford M.L., Cook D.L., Hales C.N. The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet (1985) 2 474–475.
- 50 Ashford M.L., Sturgess N.C., Trout N.J., Gardner N.J., Hales C.N. Adenosine-5′-triphosphate-sensitive ion channels in neonatal rat cultured central neurones. Pflugers Arch. (1988) 412 297–304.
- 51 Noma A. ATP-regulated K+ channels in cardiac muscle. Nature (1983) 305 147–148.
- 52 Spruce A.E., Standen N.B., Stanfield P.R. Voltage-dependent ATP-sensitive potassium channels of skeletal muscle membrane. Nature (1985) 316 736–738.
- 53 Standen N.B., Quayle J.M., Davies N.W., Brayden J.E., Huang Y., Nelson M.T. Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science (1989) 245 177–180.
- 54 Gier B., Krippeit-Drews P., Sheiko T. et al. Suppression of KATP channel activity protects murine pancreatic beta cells against oxidative stress. J. Clin. Invest. (2009) 119 3246–3256.
- 55 Takahashi A., Nagashima K., Hamasaki A. et al. Sulfonylurea and glinide reduce insulin content, functional expression of K(ATP) channels, and accelerate apoptotic beta-cell death in the chronic phase. Diabetes Res. Clin. Pract. (2007) 77 343–350.
- 56 Gomez-Lechon M.J., O’Connor E., Castell J.V., Jover R. Sensitive markers used to identify compounds that trigger apoptosis in cultured hepatocytes. Toxicol. Sci. (2002) 65 299–308.
- 57 Lennon S.V., Martin S.J., Cotter T.G. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif. (1991) 24 203–214.
Citing Literature
